The relationship between the density of Helicobacter pylori colonisation and the degree of gastritis severity

Archives of Gastroenterohepatology

Volumn 21, Issue 3-4, 2002, Pages 66-72

  Grgov, Saša ^a   Stefanovic, Milosav ^a   Katic, Vuka ^b  

^a Health Center of Leskovac   (Serbia)

^b Clinical Center Ni   (Serbia)

Author keywords

Atrophy; Gastritis activity; Helicobacter pylori; Intestinal metaplasia

Indexed keywords

ADULT; ARTICLE; ATROPHY; BACTERIAL COLONIZATION; CONTROLLED STUDY; DISEASE SEVERITY; ENDOSCOPIC BIOPSY; FEMALE; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; STAINING; STOMACH ANTRUM; STOMACH MUCOSA;

EID: 0036664350     PISSN: 03542440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Misiewiez JJ, Tytgat GNJ, Goodwin CS, et al. The Sydney system: a new classification of gastritis. Word Congress on Gastroenterology. Working Party Reports. Sydney, Blackwell Sci Publ, 1990; 1-10.
2. Sipponen P, Kekki M, Seppälä K, Siurala M. The relationships between chronic gastritis and gastric acid secretion. Aliment Pharmacol Ther 1996; 10 (Suppl 1): 103-18.
3. Price AB. The Sydney system: histologic division. J Gastroenterol Hepatol 1991; 6: 209-22.
4. Gonzaga Vaz Coelho L, León-Barúa R, and Quigley EMM. Latin-American consensus conference on Helicobaeter pylori infection. Am J Gastroenterol 2000: 95: 2688-91.
5. Stolte M, Stadelmann O, Bethke B, Burkard G. Relationship between the degree of Helicobacter pylori colonisation and the degree and activity of gastritis, surface epithelial degeneration and mucus secretion. J Gastroenterol 1995; 33: 89-93.
6. Villako K, Kekki M, Maaroos H-I, Sipponen P, Uibo R. Chronic gastritis: progression of inflammation and atrophy in a six-year endoscopic follow-up of a random sample of 142 Estonian urban subjects. Scand J Gastroenterol 1991: 26 (Suppl 186): 135-41.
7. Solcia E, Luinetti O, Villani L, Quilici P, Klersy C and Fiocca R. Intestinal metaplasia: types, mechanisms of origin, and role in gastric cancer histogenesis. In: Hunt RH and Tytgat GNJ. Helicobacter pylori - basic mechanisms to clinical cure 2000. Dordrecht. Kluwer Academic 2000: 249-54.
8. Talamini G, Zamboni G, Cavallini G. Antral mucosal Helicobacter pylori infection density as a risk factor of duodenal ulcer. Digestion 1997; 58: 211-7.
9. Dixon MF, Genta RM, Yardley JH, Correa P. Participants in the international workshop on the histopathology of gastritis. Classification and grading of gastritis: the updated Sydney system. Am J Surg Pathol 1996; 20: 1161-81.
10. Karttunen T, Niemelä S, Lehtola J. Helicobacter pylori in dyspeptic patients: quantitative association with severity of gastritis, intragastric pH, and serum gastrin concentration. Scand J Gastroenterol 1991; 26 (Suppl 186): 124-34.
11. Satoh K, Kimura K, Yoshida Y, Kasano T, Kihira K, and Taniguchi Y. A topographical relationship between Helicobacter pylori and gastritis: quantitative assessment of Helicobacter pylori in the gastric mucosa. Am J Gastroenterol 1991; 86: 285-91.
12. Sipponen P, Stolte M. Clinical impact of routine biopsies of the gastric antrum and body. Endoscopy 1997; 29: 671-8.
13. Bayerdörffer E, Oertel H, Lehn N, et al. Topographic association between active gastritis and Campylobacter pylori colonization. J Clin Pathol 1989; 42: 834-9.
14. El-Omar EM, Oien K, Murray LS, et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 2000; 118: 22-30.
15. El-Omar EM, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113: 15-24.
16. Van der Hulst RWM, van der Ende A, Dekker FW. et al. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology 1997; 113: 25-30.
17. De Francesco V, Zullo A, Rinaldi V, et al. Relationship between antral lymphocyte density and basal gastrin levels in patients with Helicobacter pylori infection. Digest Liver Dis 2000; 32: 676-81.
18. Zhang ZW and Farthing MJG. Helicobacter pylori in gastric malignancy: role of oxidants, antioxidants and other co-factors. In: Hunt RH and Tytgat GNJ. Helicobacter pylori - basic mechanisms to clinical cure 2000. Dordrecht. Kluwer Academic 2000: 513-24.
19. Hahm KB, Lee KJ, Kim JH, Cho SW, and Chung MH. Helicobacter pylori infection, oxidative DNA damage, gastric carcinogenesis, and reversibility by rebamipide. Dig Dis Sci 1998; 43: 72-7.
20. Fiocca R, Luinetti O, Villani L, Chiaravalli AM, Capella C, Solcia E. Epithelial cytotoxicity, immune responses, and inflammatory components of Helicobacter pylori gastritils. Scand J Gastroenterol 1994: 205: 11-21.
21. Genta RM. Can atrophic gastritis be diagnosed in the presence of Helicobacter pylori infection? In: Hunt RH and Tytgat GNJ. Helicobacter pylori - basic mechanisms to clinical cure 2000. Dordrecht. Kluwer Academic 2000: 229-37.
22. Lynch DA, Mapstone NP, Clarke AM, et al. Correlation between epithelial cell proliferation and histological grading in gastric mucosa. J Clin Pathol 1999; 52: 367-71.
23. Komoto K, Haruma K, Kamada T, et al. Helicobacter pylori infection and gastric neoplasia: correlations with histological gastritis and tumor histology. Am J Gastroenterol 1998; 93: 1271-6.
24. Larkin CJ, Watson RGP, Sloan JM, Stevenson M, Ardill JES and Buchanan D. Distribution of atrophy in Helicobacter pylori-infected subjects taking proton pump inhibitors. Scand J Gastroenterol 2000; 35: 578-82.